The potential role of MT and Vimentin immunoreactivity in the remodeling of the microenvironment of parotid adenocarcinoma

Cancer Microenvironment

Volumn 4, Issue 1, 2011, Pages 105-113

  Dutsch Wicherek, Magdalena ^a   Lazar, Agata ^a   Tomaszewska, Romana ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Carcinoma associated fibroblasts; Epithelial to mesenchymal transition; Metallothionein; Tumor microenvironment; Vimentin

Indexed keywords

CD56 ANTIGEN; CD57 ANTIGEN; METALLOTHIONEIN; VIMENTIN;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; CELL ADHESION; CELL INFILTRATION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; MALE; METASTASIS POTENTIAL; PALATINE TONSIL; PAROTID GLAND CARCINOMA; PAROTIDECTOMY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION;

EID: 79952532375     PISSN: 18752292     EISSN: 18752284     Source Type: Journal    
DOI: 10.1007/s12307-010-0058-z     Document Type: Article

References (43)

1. IP Witz 2009 The tumor microenvironment: the making of a paradigm Cancer Microenvironment 2 S9 17 10.1007/s12307-009-0025-8
2. AM Scott G Wiseman S Welt A Adjei FT Lee W Hopkins CR Divgi LH Hanson P Mitchell DN Gansen SM Larson JN Ingle EW Hoffman P Tanswell G Ritter LS Cohen P Bette L Arvay A Amelsberg D Vlock WJ Rettig LJ Old 2003 A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer Clin Cancer Res 9 1639 1647 12738716 1:CAS:528:DC%2BD3sXjsFeisbc%3D (Pubitemid 36554586)
3. UV Wesley AP Albino S Tiwari AN Houghton 1999 A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells J Exp Med 190 311 322 10430620 10.1084/jem.190.3.311 1:CAS:528:DyaK1MXkvFarsro%3D (Pubitemid 29374829)
4. HF Dvorak 1986 Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing N Engl J Med 315 1650 1659 3537791 10.1056/NEJM198612253152606 1:STN:280:DyaL2s%2FmsV2mtw%3D%3D (Pubitemid 17052899)
5. G Lorusso C Ruegg 2008 The tumor microenvironment and its contribution to tumor evolution toward metastasis Histochem Cell Biol 130 1091 1103 18987874 10.1007/s00418-008-0530-8 1:CAS:528:DC%2BD1cXhsVSjsr3N
6. VD Acevedo RD Gangula KW Freeman R Li Y Zhang F Wang GE Ayala LE Peterson M Ittmann DM Spencer 2007 Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition Cancer Cell 12 559 571 18068632 10.1016/j.ccr.2007.11.004 1:CAS:528:DC%2BD2sXhsVGmu73J (Pubitemid 350199071)
7. H Hugo ML Ackland T Blick MG Lawrence JA Clements ED Williams EW Thompson 2007 Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression J Cell Physiol 213 374 383 17680632 10.1002/jcp.21223 1:CAS:528:DC%2BD2sXhtFKnu7rE (Pubitemid 47509716)
8. J Xu R Wang ZH Xie V Odero-Marah S Pathak A Multani LW Chung HE Zhau 2006 Prostate cancer metastasis: role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasis Prostate 66 1664 1673 16902972 10.1002/pros.20488 1:CAS:528:DC%2BD28Xht1Oktb%2FP (Pubitemid 44646357)
9. S Grunert M Jechlinger H Beug 2003 Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis Nat Rev Mol Cell Biol 4 657 665 12923528 10.1038/nrm1175 (Pubitemid 36934968)
10. MI Kokkinos R Wafai MK Wong DF Newgreen EW Thompson M Waltham 2007 Vimentin and epithelial-mesenchymal transition in human breast cancer-observations in vitro and in vivo Cells Tissues Organs 185 191 203 17587825 10.1159/000101320 1:CAS:528:DC%2BD2sXmvFSnu70%3D (Pubitemid 46957486)
11. JP Thiery 2002 Epithelial-mesenchymal transitions in tumour progression Nat Rev Cancer 2 442 454 12189386 10.1038/nrc822 1:CAS:528:DC%2BD38Xksl2ltr8%3D
12. RJ Paccione H Miyazaki V Patel A Waseem JS Gutkind ZE Zehner WA Yeudall 2008 Keratin down-regulation in vimentin-positive cancer cells is reversible by vimentin RNA interference, which inhibits growth and motility Mol Cancer Ther 7 2894 2903 18790770 10.1158/1535-7163.MCT-08-0450 1:CAS:528:DC%2BD1cXhtFSms7fK
13. DW Powell RC Mifflin JD Valentich SE Crowe JI Saada AB West 1999 Myofibroblasts. I. Paracrine cells important in health and disease Am J Physiol 277 C1 C9 10409103 1:CAS:528:DyaK1MXkslKgtLY%3D
14. M Vered I Allon A Buchner D Dayan 2009 Stromal myofibroblasts accompany modifications in the epithelial phenotype of tongue dysplastic and malignant lesions Cancer Microenvironment 2 49 57 19424824 10.1007/s12307-009-0020-0 1:CAS:528:DC%2BD1MXhsFKrs7fE
15. O De Wever M Mareel 2005 Role of tissue stroma in cancer cell invasion J Pathol 200 429 447 10.1002/path.1398
16. SW Hayward Y Wang M Cao YK Hom B Zhang GD Grossfeld D Sudilovsky GR Cunha 2001 (2001) Malignant transformation in a nontumorigenic human prostatic epithelial cell line Cancer Res 61 8135 8142 11719442 1:CAS:528: DC%2BD3MXovVShs7s%3D (Pubitemid 33091604)
17. A Orimo PB Gupta DC Sgroi F Arenzana-Seisdedos T Delaunay R Naeem VJ Carey AL Richardson RA Weinberg 2005 Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion Cell 121 335 348 15882617 10.1016/j.cell.2005.02.034 1:CAS:528:DC%2BD2MXktlSiu7w%3D (Pubitemid 40692295)
18. H Sugimoto TM Mundel MW Kieran R Kalluri 2006 Identification of fibroblast heterogeneity in the tumor microenvironment Cancer Biol Ther 5 1640 1646 17106243 10.4161/cbt.5.12.3354 1:CAS:528:DC%2BD2sXksVyru7c%3D
19. CD Klaassen J Liu S Choudhuri 1999 Metallothionein: an intracellular protein to protect against cadmium toxicity Annu Rev Pharmacol Toxicol 39 267 294 10331085 10.1146/annurev.pharmtox.39.1.267 1:CAS:528:DyaK1MXjtVejtL4%3D (Pubitemid 29222560)
20. MD Apostolova MG Cherian 2000 Nuclear localization of metalothionein during cell proliferation and differentiation Cell Mol Biol 46 347 356 10774924
21. SE Theocharis AP Margeli JT Klijanienko GP Kouraklis 2004 Metallothionein expression in human neoplasia Histopathology 45 103 18 15279628 10.1111/j.1365-2559.2004.01922.x 1:STN:280:DC%2BD2czns12jsg%3D%3D (Pubitemid 39120406)
22. MG Cherian A Jayasurya BH Bay 2003 Metallothioneins in human tumors and potential roles in carcinogenesis Mutat Res 33 201 209 (Pubitemid 37487869)
23. LZ Fan MG Cherian 2002 Potential role of p53 on metallothionein induction in human epithelial breast cancer cells Br J Cancer 87 1019 1026 12434295 10.1038/sj.bjc.6600549 1:CAS:528:DC%2BD38Xoslalu7Y%3D (Pubitemid 35305656)
24. M Dutsch-Wicherek TJ Popiela M Klimek L Rudnicka-Sosin L Wicherek JP Oudinet J Skladzien R Tomaszewska 2005 Metallothionein stroma reaction in tumor adjacent healthy tissue in head and neck squamous cell carcinoma and breast adenocarcinoma NeuroEndocrinol Lett 26 567 574 16264399 1:STN:280: DC%2BD2MnmvF2ktw%3D%3D (Pubitemid 43013733)
25. M Dutsch-Wicherek J Sikora R Tomaszewska 2008 The possible biological role of metallothionein in apoptosis Front Biosci 13 4029 4038 18508497 10.2741/2991 1:CAS:528:DC%2BD1cXnsVKqu78%3D (Pubitemid 351599675)
26. HB Hellquist 1997 Apoptosis in epithelial hyperplastic laryngeal lesions Acta Otolaryngol Suppl 527 25 29 9197476 10.3109/00016489709124029 1:STN:280:DyaK2szktFSjsA%3D%3D (Pubitemid 27241740)
27. K Sundelin M Jadner L Norberg-Spaak A Davidsson HB Hellquist 1997 Metallothionein and Fas (CD95) are expressed in squamous cell carcinoma of the tongue Eur J Cancer 33 1860 1864 9470847 10.1016/S0959-8049(97)00216-5 1:STN:280:DyaK1c7jtFKhsQ%3D%3D (Pubitemid 28129218)
28. T Okada T Iiai Y Kawachi T Moroda Y Takii K Hatakeyama T Abo 1995 Origin of CD57+ T cells which increase at tumour sites in patients with colorectal cancer Clin Exp Immunol 102 159 166 7554383 10.1111/j.1365-2249.1995.tb06650.x 1:STN:280:DyaK28%2Fgtl2ltw%3D%3D
29. Y Takii S Hashimoto T Iiai H Watanabe K Hatakeyama T Abo 1994 Increase of the proportion of granulated CD56+ T cells in patients with malignancy J Clin Exp Immunol 97 522 527 10.1111/j.1365-2249.1994.tb06120.x 1:STN:280: DyaK2czmtl2hsw%3D%3D (Pubitemid 24283900)
30. M Satoh S Seki W Hashimoto K Ogasawara T Kobayashi K Kumagai S Matsuno K Takeda 1996 Cytotoxic gammadelta or alphabeta T cells with a natural killer cell marker, CD56, induced from human peripheral blood lymphocytes by a combination of IL-12 and IL-2 J Immunol 157 3886 3892 8892619 1:CAS:528:DyaK28XmsF2lsLo%3D (Pubitemid 126449296)
31. I Kuss B Hathaway RL Ferris W Gooding TL Whiteside 2004 Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck Clin Cancer Res 10 3755 3762 15173082 10.1158/1078-0432.CCR-04-0054 1:CAS:528:DC%2BD2cXksVKntrs%3D (Pubitemid 38697609)
32. F Sallusto J Geminat A Lanzavecchia 2004 Central memory and effector memory T cell subsets: function, generation, and maintenance Annu Rev Immunol 22 745 763 15032595 10.1146/annurev.immunol.22.012703.104702 1:CAS:528: DC%2BD2cXktlOgsb8%3D (Pubitemid 38680440)
33. A Jayasurya BH Bay WM Yap NG Tan 2000 Correlation of metallothionein expression with apoptosis in nasopharyngeal carcinoma Br J Cancer 82 1198 1203 10735506 10.1054/bjoc.1999.1063 1:CAS:528:DC%2BD3cXisFSktrw%3D (Pubitemid 30128879)
34. A Jayasurya BH Bay WM Yap NG Tan 2000 Infiltrating lymphocytes in undifferentiated nasopharyngeal cancer lack metallothionein expression Cancer Lett 155 99 104 10814885 10.1016/S0304-3835(00)00414-6 1:CAS:528: DC%2BD3cXjt1ejsb0%3D (Pubitemid 30256230)
35. TJ Popiela L Rudnicka-Sosin M Dutsch-Wicherek M Klimek P Basta K Galazka L Wicherek 2006 The metallothionein and RCAS1 expression analysis in breast cancer and adjacent tissue regarding the immune cells presence and their activity NeuroEndocrinol Lett 27 786 794 17187007 1:CAS:528:DC%2BD2sXhsFygt7Y%3D (Pubitemid 46138640)
36. MQ Gao BG Kim S Kang YP Choi H Park KS Kang NH Cho 2010 Stromal fibroblasts from the interface zone of human breast carcinomas induce an epithelial-mesenchymal transition-like state in breast cancer cells in vitro J Cell Sci 123 3507 3514 20841377 10.1242/jcs.072900 1:CAS:528:DC%2BC3cXhsFSntb7O
37. E Canpolat MA Lynes 2001 In vivo manipulation of endogenous metallothionein with a monoclonal antibody enhances a T-dependent humoral immune response Toxicol Sci 62 61 70 11399794 1:CAS:528:DC%2BD3MXks1GgurY%3D (Pubitemid 32611362)
38. HL Ioachim 1979 The stroma reaction of tumors: An expression of immune surveillance J Cell Biochem Suppl 57 465 475
39. SE Keller HL Ioachim T Pearse DM Siletti 1976 Decreased T-lymphocytes in patients with mammary cancer Am J Clin Pathol 65 445 449 178170 1:STN:280:DyaE287otFOruw%3D%3D
40. S Miescher TL Whiteside L Moretta V Von Fliedner 1987 Clonal and frequency analyses of tumor infiltrating T lymphocytes from human solid tumors J Immunol 138 4004 4011 3108380 1:STN:280:DyaL2s3isVSmtg%3D%3D (Pubitemid 17078287)
41. TR Mosmann H Cherwinski MW Bond MA Giedlin RL Coffman 1986 Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins J Immunol 136 2348 2357 2419430 1:CAS:528:DyaL28XhvVClsbk%3D (Pubitemid 16136806)
42. G Trinchieri 1995 Interleukin-12- a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cell type 1 and cytotoxic lymphocytes Blood 84 4008 4027 (Pubitemid 24371902)
43. U Elsässer-Beile N Kölble T Grussenmeyer W Schultze-Seemann U Wetterauer H Gallati J Schulte Mönting S von Kleist 1998 Th1 and Th2 cytokine response patterns in leukocyte cultures of patients with urinary bladder, renal cell and prostate carcinomas Tumor Biol 19 470 476 10.1159/000030039 (Pubitemid 28539329)